Serum Neurofilament Light Chain Levels and NEDA-3 Status With Ofatumumab Treatment in RMS Patients: Longer-term Analysis from ASCLEPIOS I/II and ALITHIOSJ. Kuhle,L. Kappos, T. Ziemssen,D. L. Arnold,E. Alvarez,A. H. Cross,I. Boer,A. D. Gupta,X. Hu, P. Kukkaro, B. Kieseier, R. Zielman,S. L. HauserMULTIPLE SCLEROSIS JOURNAL（2022）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
